Faron Pharmaceuticals Oy Share Price, News & Analysis (LON:FARN) GBX 274 +14.00 (+5.38%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range 250▼ 27450-Day Range 251▼ 35052-Week Range 218.86▼ 395Volume20,699 shsAverage Volume9,510 shsMarket Capitalization£188.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines About Faron Pharmaceuticals Oy Stock (LON:FARN)Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. It also develops Haematokine, an investigational AOC3 inhibitor that is used for regenerative medicines in hematological malignancies, as well as chemotherapy induced suppression of the bone marrow. In addition, the company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.Read More FARN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FARN Stock News HeadlinesDecember 2, 2023 | americanbankingnews.comFaron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Below 50 Day Moving Average of $288.06November 24, 2023 | morningstar.comFaron Pharmaceuticals Oy FARNDecember 2, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 6, 2023 | finance.yahoo.comFaron Pharmaceuticals initiates second phase of BEXMAB studyNovember 6, 2023 | finance.yahoo.comFaron Pharmaceuticals Oy's (LON:FARN) last week's 11% decline must have disappointed individual investors who have a significant stakeNovember 2, 2023 | finance.yahoo.comFaron to Present Phase 1/2 Data From BEXMAB Study of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies at the 65th American Society of Hematology Annual MeetingOctober 27, 2023 | proactiveinvestors.comFaron Pharma raises €7.1m as cancer study continues apaceOctober 27, 2023 | finance.yahoo.comInside Information: Announcement of the Results of Placing, the Issue Price and registration of Placing Shares with the Trade RegisterDecember 2, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 16, 2023 | proactiveinvestors.comFaron Pharmaceuticals' chief speaks after latest promising BEXMAB trial dataOctober 11, 2023 | proactiveinvestors.comFaron Pharma data 'extremely encouraging', says CEOOctober 11, 2023 | proactiveinvestors.comFaron Pharmaceuticals data 'highly encouraging', say bankOctober 11, 2023 | finance.yahoo.comInside information: Faron Announces Positive BEXMAB Study Update in Relapsed/Refractory AML and HMA-Refractory MDS PatientsOctober 3, 2023 | finance.yahoo.comFaron to Host Webcast to Discuss New Data From Phase I/II BEXMAB Study of Bexmarilimab and Provide Update on the Development Outlook for Next 6-9 MonthsSeptember 26, 2023 | finance.yahoo.comBreakeven On The Horizon For Faron Pharmaceuticals Oy (LON:FARN)September 22, 2023 | markets.businessinsider.comFaron Pharmaceuticals Ltd Results of the Extraordinary General MeetingSeptember 22, 2023 | finance.yahoo.comFaron Pharmaceuticals Announces Board ChangesSeptember 22, 2023 | finance.yahoo.comFaron Pharmaceuticals Ltd Results of the Extraordinary General MeetingSeptember 21, 2023 | reuters.comBRIEF-Faron Pharmaceuticals Appoints Birge Berns As Interim Chief Medical OfficerSeptember 21, 2023 | proactiveinvestors.comFaron Pharma appoints new chief medical officerSeptember 21, 2023 | finanznachrichten.deFaron Pharmaceuticals Oy: Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical OfficerSeptember 21, 2023 | finance.yahoo.comFaron Appoints Dr. Birge Berns, MD as Interim Chief Medical OfficerSeptember 6, 2023 | finance.yahoo.comFaron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 1, 2023 | finance.yahoo.comFaron Pharmaceuticals kicks off second half with FDA announcementAugust 30, 2023 | finance.yahoo.comFaron Pharmaceuticals Oy's (LON:FARN) Intrinsic Value Is Potentially 98% Above Its Share PriceAugust 29, 2023 | finanznachrichten.deFaron Pharmaceuticals Oy: Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid LeukemiaAugust 29, 2023 | finance.yahoo.comFaron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid LeukemiaSee More Headlines Receive FARN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Faron Pharmaceuticals Oy and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:FARN CUSIPN/A CIKN/A Webwww.faron.com Phone+358-2-4695151FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-29,340,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-113.62% Debt Debt-to-Equity Ratio121.51 Current Ratio1.08 Quick Ratio1.09 Sales & Book Value Annual Sales£-725,000.00 Price / Sales-259.98 Cash FlowGBX 13.70 per share Price / Cash Flow20.00 Book ValueGBX (14) per share Price / Book-19.57Miscellaneous Outstanding Shares68,790,000Free FloatN/AMarket Cap£188.48 million OptionableNot Optionable Beta-0.06 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Juho Markku Jalkanen M.D. (Age 45)MSc, Ph.D., Chief Operating Officer Comp: $554.15kDr. Markku Tapani Jalkanen Ph.D. (Age 69)Founder, CEO & Executive Director Comp: $245.38kMr. James M. O'Brien CPAM.B.A., Chief Financial OfficerDr. Maija Hollmen Ph.D.Chief Scientific OfficerMr. Vesa Karvonen L.L.M. (Age 51)General Counsel Ms. Jennifer Smith-ParkerHead of CommunicationsMr. Juuso Vakkuri M.A.M.B.A., M.Sc., Chief Human Resources OfficerDr. Juhana HeinonenChief Commercial OfficerDr. Birge Berns M.D.Interim Chief Medical OfficerMore ExecutivesKey CompetitorsOxford BiomedicaLON:OXBBioventixLON:BVXPArix BioscienceLON:ARIXCircassia GroupLON:CIRhVIVOLON:HVOView All CompetitorsInsidersJohn PoulosSold 5,000 sharesTotal: £1.92 M ($383.00/share)John PoulosSold 5,000 sharesTotal: £1.86 M ($372.00/share) FARN Stock Analysis - Frequently Asked Questions How have FARN shares performed in 2023? Faron Pharmaceuticals Oy's stock was trading at GBX 300 at the beginning of 2023. Since then, FARN stock has decreased by 8.7% and is now trading at GBX 274. View the best growth stocks for 2023 here. What other stocks do shareholders of Faron Pharmaceuticals Oy own? Based on aggregate information from My MarketBeat watchlists, some companies that other Faron Pharmaceuticals Oy investors own include Horizon Discovery Group plc (HZD.L) (HZD), Acura Pharmaceuticals (ACUR), Carnival Co. & (CCL), Alphabet (GOOG), Hurricane Energy (HUR), International Consolidated Airlines Group (IAG), Northwest Pipe (NWPX), Petropavlovsk (POG) and TriQuint Semiconductor (TQNT). How do I buy shares of Faron Pharmaceuticals Oy? Shares of FARN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:FARN) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.